HealthEquity Reports Third Quarter Ended October 31, 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
HealthEquity (HQY) Tops Q3 EPS by 7c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
December 7, 2020 4:04 PM ESTHealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $179.4 million versus the consensus estimate of $176.78 million.
Highlights of the third quarter include:
Revenue of $179.4 million, an increase of 14% compared to $157.1 million in Q3 FY20.Net income of $1.8 million, with non-GAAP net income of $32.2 million, compared to net loss of $21.3 million and non-GAAP net income of $30.3 million in Q3 FY20.Net income per diluted share of $0.02, with non-GAAP net income per diluted share of $0.41,... More